Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial (Q34182887)
scientific article
Language:
Current Data About Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial
(P31) (Q13442814)
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

(P304) 73-78
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

(P407) (Q1860)

(P433) 2
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

(P478) 316
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

(P577) Thursday, January 1, 1987
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

(P921) (Q5452194)

(Q218706)
(P887)

(Q1054718)
(P887)

(P1433) (Q582728)
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

(P1476) "Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial" (language: en)
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

(P2093) Eschbach JW
(P1545) 1
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

Egrie JC
(P1545) 2
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

Downing MR
(P1545) 3
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

Browne JK
(P1545) 4
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

Adamson JW
(P1545) 5
(P248)
(P698) 3537801
(P813) Monday, July 31, 2017

other details
description scientific article

External Links
(P356) 10.1056/NEJM198701083160203
(P698) 3537801